Jullian Pham Nguyen, MD
Family Practice · Hollister
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 2
Offices
2 locations · Hazel Hawkins Memorial Hospital · El Camino Health Medical Network LLC
Hospitals listed: 559775 · El Camino Health · Hazel Hawkins Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A175208 · Current
Licensed to practise in California · since 2021 · expires 2027-10-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Texas BP10062852Physician-in-Training Permit · since 2018 · expires 2021-06-30Permit TerminatedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Hazel Hawkins Memorial HospitalHollister, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Hazel Hawkins Memorial Hospital
Behind the star rating — Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.1) · 409 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 43 cases | No different | Jan 2024 – Dec 2024 |
Original Medicare doctor bills
$73,522
Medicare paid this office $73,522 for 284 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 115 | $22,446 | $110 |
| Short return visit (20+ min) | 193 | $19,144 | $84 |
| Aspiration and/or injection of fluid from large joint | 24 | $2,179 | $61 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $1,669 | $49 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 22 | $1,106 | $50 |
See all 6 services
| Return visit (30+ min) | 115 | $22,446 | $110 |
| Short return visit (20+ min) | 193 | $19,144 | $84 |
| Aspiration and/or injection of fluid from large joint | 24 | $2,179 | $61 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $1,669 | $49 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 22 | $1,106 | $50 |
| Urinalysis, manual test | 28 | $99 | $3 |
Who their Medicare patients are
284 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 17% · Women 66% · Also on Medicaid 18% · Health risk score 1.06. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 70% · Diabetes 30% · Coronary heart disease 25% · Chronic kidney disease 21% · Depression 19% · Heart failure 16% · Atrial fibrillation 15% · COPD 14% · Cancer 12% · Stroke 7% · Dementia 6%.
The office billed $231,013, Medicare allowed $97,427 and paid $73,522; for 3,012 services of 42 kinds; $22,876 of it was for drugs given in the office and $50,645 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 284 | 3,012 | 75 | 1.06 | $231,013 | $73,522 |
| 2023 | 95 | 1,499 | 73 | 0.99 | $102,770 | $39,746 |
| 2022 | 26 | 296 | 73 | 0.81 | $19,140 | $7,098 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 77 | $18,804 | $112 |
| Aspiration and/or injection of fluid from large joint | 32 | $2,824 | $63 |
| Short return visit (20+ min) | 29 | $2,796 | $85 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $839 | $47 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $156 | None |
2022: 1 service
| Return visit (30+ min) | 18 | $2,957 | $123 |
Medicaid work
$103,716 in 2024
Medicaid paid $103,716 for 1,346 billed services this clinician did in 2024, up to 86 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 721 | $103,716 |
| Short return visit | 247 | $0 |
| Short return visit (20+ min) | 92 | $0 |
| Return visit (30+ min) | 265 | $0 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 21 | $0 |
| 2024 | 1,346 | 5 | 86 | $103,716 |
| 2023 | 1,598 | 6 | 88 | $146,751 |
| 2022 | 1,043 | 4 | 100 | $110,309 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 895 | $146,061 |
| Measurement of vitamin D 25 hydroxy | 13 | $462 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $228 |
| Short return visit | 61 | $0 |
| Short return visit (20+ min) | 169 | $0 |
| Return visit (30+ min) | 448 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 621 | $110,309 |
| Short return visit | 82 | $0 |
| Short return visit (20+ min) | 230 | $0 |
| Return visit (30+ min) | 110 | $0 |
Drugs they prescribed that Part D paid
$235,615
Pharmacies billed $235,615 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 1,852) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,592 generic and fewer than 11 brand-name prescriptions · $235,615 in drug cost · 138 antibiotic prescriptions to 116 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 40 | $50,907 | $1,273 |
| Ozempic | 24 | $28,177 | $1,174 |
| Xarelto | 15 | $24,957 | $1,664 |
| Jardiance | 17 | $23,676 | $1,393 |
| Eliquis | 11 | $15,966 | $1,451 |
See all 46 drugs
| Mounjaro | 40 | $50,907 | $1,273 |
| Ozempic | 24 | $28,177 | $1,174 |
| Xarelto | 15 | $24,957 | $1,664 |
| Jardiance | 17 | $23,676 | $1,393 |
| Eliquis | 11 | $15,966 | $1,451 |
| Trulicity | 12 | $12,593 | $1,049 |
| Atorvastatin | 158 | $1,767 | $11 |
| Duloxetine | 21 | $1,607 | $77 |
| Paxlovid | 16 | $1,429 | $89 |
| Methocarbamol | 20 | $974 | $49 |
| Rosuvastatin | 33 | $924 | $28 |
| Albuterol Sulfate Hfa | 39 | $854 | $22 |
| Gabapentin | 42 | $715 | $17 |
| Diclofenac | 19 | $704 | $37 |
| Omeprazole | 36 | $656 | $18 |
| Trazodone | 57 | $504 | $9 |
| Tamsulosin | 38 | $441 | $12 |
| Levothyroxine | 42 | $408 | $10 |
| Metformin Hcl Er | 25 | $394 | $16 |
| Pantoprazole | 37 | $394 | $11 |
| Nitrofurantoin Mono-Macro | 32 | $378 | $12 |
| Losartan | 32 | $352 | $11 |
| Lisinopril | 55 | $329 | $6 |
| Amoxicillin-Clavulanate Potass | 57 | $303 | $5 |
| Amlodipine Besylate | 61 | $302 | $5 |
| Famotidine | 14 | $240 | $17 |
| Benazepril | 27 | $227 | $8 |
| Hydrochlorothiazide | 56 | $226 | $4 |
| Metformin | 39 | $226 | $6 |
| Alendronate | 19 | $224 | $12 |
| Potassium Chloride | 13 | $213 | $16 |
| Hydralazine | 14 | $202 | $14 |
| Escitalopram | 15 | $187 | $12 |
| Irbesartan | 11 | $177 | $16 |
| Metoprolol | 13 | $171 | $13 |
| Simvastatin | 17 | $161 | $9 |
| Fluticasone Propionate | 18 | $148 | $8 |
| Olmesartan Medoxomil | 13 | $117 | $9 |
| Mupirocin | 15 | $114 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $103 | $9 |
| Zolpidem | 12 | $98 | $8 |
| Carvedilol | 22 | $92 | $4 |
| Atenolol | 15 | $82 | $5 |
| Meloxicam | 26 | $66 | $3 |
| Triamcinolone Acetonide | 14 | $61 | $4 |
| Furosemide | 15 | $49 | $3 |
Year by year
| 2024 | 1,852 | 345 | 1% (13) | None | $235,615 |
| 2023 | 693 | 100 | 2% (15) | 11% | $106,324 |
| 2022 | 188 | 58 | None | None | $13,353 |
| 2021 | 357 | 65 | 0% (0) | 14% | $47,114 |
| 2020 | 613 | 58 | 0% (0) | None | $71,241 |
| 2019 | 403 | 57 | 0% (0) | None | $42,669 |
| 2018 | 35 | None | 0% (0) | 31% | $6,740 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Ozempic | 20 | $28,844 | $1,442 |
| Duloxetine | 14 | $2,541 | $182 |
| Atorvastatin | 50 | $1,486 | $30 |
| Trazodone | 20 | $697 | $35 |
| Diclofenac | 20 | $561 | $28 |
| Omeprazole | 17 | $536 | $32 |
| Tamsulosin | 15 | $526 | $35 |
| Benazepril | 18 | $521 | $29 |
| Amlodipine Besylate | 30 | $503 | $17 |
| Lisinopril | 21 | $502 | $24 |
| Levothyroxine | 23 | $363 | $16 |
| Fluticasone Propionate | 14 | $301 | $21 |
| Simvastatin | 12 | $248 | $21 |
| Gabapentin | 18 | $196 | $11 |
| Alendronate | 12 | $137 | $11 |
| Carvedilol | 13 | $95 | $7 |
| Hydrochlorothiazide | 15 | $81 | $5 |
| Amoxicillin-Clavulanate Potass | 11 | $69 | $6 |
2022: 4 drugs
| Diclofenac | 14 | $370 | $26 |
| Atorvastatin | 14 | $287 | $20 |
| Lisinopril | 14 | $148 | $11 |
| Amlodipine Besylate | 12 | $102 | $9 |
2021: 8 drugs
| Rosuvastatin | 24 | $514 | $21 |
| Levothyroxine | 14 | $413 | $29 |
| Metoprolol | 14 | $164 | $12 |
| Losartan | 12 | $152 | $13 |
| Amlodipine Besylate | 21 | $124 | $6 |
| Atorvastatin | 11 | $110 | $10 |
| Benazepril | 15 | $87 | $6 |
| Hydrochlorothiazide | 14 | $61 | $4 |
2020: 15 drugs
| Trulicity | 15 | $21,988 | $1,466 |
| Levothyroxine | 26 | $486 | $19 |
| Prasugrel | 11 | $337 | $31 |
| Atorvastatin | 43 | $323 | $8 |
| Rosuvastatin | 18 | $212 | $12 |
| Pantoprazole | 13 | $207 | $16 |
| Pravastatin | 11 | $204 | $19 |
| Potassium Chloride | 19 | $182 | $10 |
| Alendronate | 14 | $180 | $13 |
| Amlodipine Besylate | 35 | $176 | $5 |
| Gabapentin | 15 | $171 | $11 |
| Metoprolol | 21 | $128 | $6 |
| Clopidogrel | 12 | $98 | $8 |
| Tamsulosin | 11 | $84 | $8 |
| Hydrochlorothiazide | 14 | $42 | $3 |
2019: 8 drugs
| Trulicity | 16 | $12,598 | $787 |
| Rosuvastatin | 19 | $389 | $20 |
| Levothyroxine | 17 | $326 | $19 |
| Pantoprazole | 12 | $203 | $17 |
| Atorvastatin | 14 | $135 | $10 |
| Amlodipine Besylate | 17 | $133 | $8 |
| Metformin Hcl Er | 12 | $113 | $9 |
| Metoprolol | 12 | $54 | $4 |
Money from drug and device companies
$695 in 2025
| 2025 | 9 | 25 | None | $695 |
| 2024 | 7 | 7 | None | $138 |
| 2023 | 8 | 9 | None | $281 |
| 2022 | 2 | 2 | None | $72 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 1 | 1 | None | $21 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bayer Healthcare Pharmaceuticals | Kerendia | $200 | 4 payments
|
| Abbvie | Qulipta | $144 | 9 payments
|
| Lilly USA | Jardiance | $125 | 1 payment
|
| Amgen | Otezla | $89 | 5 payments
|
| Otsuka America Pharmaceutical | Rexulti | $53 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
See all 25 published payments
| Abbvie | Meals · 2025-11-14 | Qulipta | $23 |
| SK Life Science | Meals · 2025-11-13 | None | $19 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-07 | Kerendia | $150 |
| Abbvie | Meals · 2025-11-06 | Ubrelvy | $12 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-30 | Kerendia | $17 |
| Amgen | Meals · 2025-10-06 | Otezla | $15 |
| Abbvie | Meals · 2025-09-11 | Ubrelvy | $11 |
| Abbvie | Meals · 2025-09-03 | Qulipta | $20 |
| Abbvie | Meals · 2025-08-20 | Qulipta | $17 |
| Pfizer | Meals · 2025-07-25 | Nurtec Odt | $21 |
| Abbvie | Meals · 2025-07-09 | Qulipta | $24 |
| Abbvie | Meals · 2025-06-27 | Qulipta | $7 |
| Otsuka America Pharmaceutical | Meals · 2025-06-25 | Rexulti | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-04 | Kerendia | $16 |
| Amgen | Meals · 2025-06-02 | Otezla | $18 |
| Lilly USA | Meals · 2025-05-21 | Jardiance | $125 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-07 | Jardiance | $22 |
| Amgen | Meals · 2025-05-05 | Otezla | $19 |
| Abbvie | Meals · 2025-04-30 | Ubrelvy | $9 |
| Amgen | Meals · 2025-04-07 | Otezla | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-03-21 | Rexulti | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-12 | Kerendia | $16 |
| Abbvie | Meals · 2025-03-07 | Ubrelvy | $20 |
| Amgen | Meals · 2025-03-03 | Otezla | $16 |
| Eisai | Meals · 2025-01-10 | Leqembi | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $138
| Eisai | Leqembi | $30 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $26 | 1 payment
|
| SK Life Science | None | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $15 | 1 payment
|
| Lilly USA | Kisunla | $14 | 1 payment
|
2023: $281
| Medtronic | Eea | $116 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $34 | 2 payments
|
| Lilly USA | Amyvid | $30 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $23 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $21 | 1 payment
|
| MannKind | Afrezza | $21 | 1 payment
|
| Averitas Pharma | Qutenza | $21 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $15 | 1 payment
|
2022: $72
| Pacira Pharmaceuticals | Iovera | $56 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
2021: $17
| Amgen | Repatha | $17 | 1 payment
|
2020: $21
| Lilly USA | Trulicity | $21 | 1 payment
|
Professional record
- NPI
- 1548764400
- Licence
- CA A175208, TX BP10062852California A175208: Current · expires 2027-10-31Texas BP10062852: Permit Terminated
- Group
- Hazel Hawkins Memorial Hospital · El Camino Health Medical Network LLC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X); Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 890 Sunset Dr, Building A Suite 2a, Hollister, CA, 95023
- NPI first listed
- 2018-03-23
- NPI last updated
- 2023-03-08
- NPI record certified
- 2023-03-08
This is when the NPI record was last certified, not a medical board exam.